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Abstract
Background: There is a growing emphasis on self-monitoring applications that allow patients to measure their own
physical health parameters. A prerequisite for achieving positive effects is patients’ willingness to self-monitor. The
controllability of disease types, patients’ perceived self-efficacy and health problems could play an essential role in this.
The purpose of this study is to investigate the relationship between patients’ willingness to self-monitor and a range of
disease and patient specific variables including controllability of disease type, patients’ perceived self-efficacy and
health problems.
Methods: Data regarding 627 participants with 17 chronic somatic disease types from a Dutch panel of people with
chronic diseases have been used for this cross-sectional study. Perceived self-efficacy was assessed using the general
self-efficacy scale, perceived health problems using the Physical Health Composite Score (PCS). Participants indicated
their willingness to self-monitor. An expert panel assessed for 17 chronic disease types the extent to which patients
can independently keep their disease in control. Logistic regression analyses were conducted.
Results: Patients’ willingness to self-monitor differs greatly among disease types: patients with diabetes (71.0%), asthma
(59.6%) and hypertension (59.1%) were most willing to self-monitor. In contrast, patients with rheumatism (40.0%),
migraine (41.2%) and other neurological disorders (42.9%) were less willing to self-monitor. It seems that there might
be a relationship between disease controllability scores and patients’ willingness to self-monitor. No evidence is found
of a relationship between general self-efficacy and PCS scores, and patients’ willingness to self-monitor.
Conclusions: This study provides the first evidence that patients’ willingness to self-monitor might be associated with
disease controllability. Further research should investigate this association more deeply and should focus on how
disease controllability influences willingness to self-monitor. In addition, since willingness to self-monitor differed
greatly among patient groups, it should be taken into account that not all patient groups are willing to self-monitor.
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Background
In recent decades there has been a growing emphasis on
self-monitoring applications in primary care. These ap-
plications allow patients to measure their own physical
health parameters, such as blood pressure, blood glucose
level and lung function [1–3]. Self-monitoring is a key
aspect of patients’ self-management [4], especially in dis-
eases like diabetes, asthma and heart failure. It offers the
potential to create awareness of symptoms, bodily sensa-
tions, daily activities and cognitive processes and to provide
information for action [5]. The effects of self-monitoring
look promising: literature shows that it could improve
self-management, symptom management and disease
regulation, and could lead to reductions in complica-
tions, improved patients’ coping and attitudes toward
their disease, realistic goal setting and an enhanced
quality of life [6]. Self-monitoring is a broad term,
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including the monitoring of clinical parameters, symp-
tom measures and daily activities [5]. In the current
study we focus on individual self-monitoring of clinical
parameters (such as: weight, blood pressure, blood glu-
cose level and lung function) with the use of technical
equipment.
With the introduction of new technologies, self-
monitoring has become more convenient and accessible
for patients. However, a prerequisite for achieving the
positive effects of self-monitoring is the willingness of
patients to self-monitor. Patients’ willingness to use tech-
nologies in health care is often studied with the Technol-
ogy Acceptance Model (TAM) [7, 8]. This model theorizes
that beliefs about perceived ease of use and perceived use-
fulness are the main constructs predicting user intention.
A recent review study shows that the TAM is still the most
important model used to identify the factors that influence
the adoption of information technologies in health care [9].
This model had been extended and modified in recent
years, such as in the Unified Theory of Acceptance and
Use of Technology (UTAUT) [10]. Besides ease of use and
perceived usefulness two other key constructs are included
in the UTAUT model: social influence and facilitating con-
ditions. However, we suggest that there are other under-
lying disease-specific and patient-specific factors that play
an essential role in patients’ willingness to self-monitor.
For instance, the relevance of self-monitoring may not
be the same for each disease type. For patients with dia-
betes and hypertension, for example, self-management
goals are easy to define, such as optimizing blood glu-
cose level and blood pressure, which are parameters that
can easily be monitored by the patient. For patients with
a disease like arthritis these goals are less concrete [11].
Moreover, other researchers suggest that in disease types
such as diabetes, the feedback between action and change
is rather direct and can clearly be observed by the patient,
which can trigger the sensemaking process of performing
self-management behaviour. For disease types such as
cancer there are less direct and easily captured indicators
that can activate this process [12].
Hence, it would seem that disease types differ in the
extent to which they are controllable by the patients’ be-
haviour (e.g., using medication, nutrition and physical
activity), which could be related to patients’ willingness
to self-monitor. Some support for this was found in a
recently performed focus group study [13]. In this study
we found that patients with diabetes were more inter-
ested in the use of self-monitoring than patients with a
Chronic Obstructive Pulmonary Disease (COPD) and a
cardiovascular condition, because they mentioned that
their own behaviour (nutrition, weight loss and medica-
tion) directly influenced their health, and that self-
monitoring support could help them to influence their
behaviour.
However, disease controllability does not only differ
between disease types, but can also differ between individ-
uals. Patients’ belief that they are capable of managing and
controlling their disease is better known as self-efficacy
[14]. This plays an important role in performing self-
management behaviour [15] and might likewise influence
patients’ willingness to self-monitor. Previous research
found that higher perceived self-efficacy was associated
with better blood glucose monitoring in patients with
diabetes [16, 17].
Besides self-efficacy, the benefits that patients experi-
ence from self-monitoring might play an important role
in their willingness to self-monitor. According to the
Health Belief Model [18], perceiving higher benefits in
relation to costs improves the performance of health be-
haviour. This is also found to be related to adherence to
self-monitoring in patients with diabetes [19]. Experienced
benefits regarding self-monitoring could be the reduction
or prevention of disease symptoms. In our focus group
study we found that patients with a chronic disease who
experienced minimal health complaints were less willing
to self-monitor because they expected fewer benefits.
They did not expect improvements in their health, be-
cause their disease had little impact on their life, and were
more focused on the perceived costs; the time it takes to
do the self-monitoring [13]. Therefore in terms of self-
monitoring we argue that patients who experience more
severe health problems perceive higher benefits from self-
monitoring (improvements in their health) in relation to
the costs (doing the self-monitoring) and might likewise
be more willing to self-monitor.
Up until now self-monitoring is often not yet inte-
grated in standard care procedures. Moreover, the role
of the patient and health care professional regarding the
provision of self-monitoring is not yet defined. This
study aimed to get more insight in willingness to self-
monitor by patients with different chronic disease types.
In this study our hypotheses which were based on the
results of the focus group study are tested in a wider
range of disease types to answer the following research
question: what is the relationship between the control-
lability of disease types (disease specific) and patients’
perceived self-efficacy and health problems (patient
specific) on the one hand, and patients’ willingness to
self-monitor on the other. In addition, the influence of
patients’ characteristics (gender, age, level of education
and multimorbidity) on patients’ willingness to self-monitor
will be investigated. Based on the previously performed
focus group study we generated three hypotheses:
Disease-specific hypothesis:
1. The controllability of a certain type of chronic disease
is related to patients’ willingness to self-monitor; patients
with a chronic disease that can be, in general, properly
kept under control by the patient will be more interested
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in self-monitoring than patients that have a disease that is
less controllable by the patient.
Patient-specific hypotheses:
2. Patient’s perceived self-efficacy is related to their
willingness to self-monitor; patients with high perceived
self-efficacy are more interested in self-monitoring than
patients that perceive low self-efficacy.
3. The severity of problems that patients experience
with daily functioning is related to their willingness to
self-monitor; patients that have moderate problems with
daily functioning are more interested in self-monitoring
than patients who perceive no problems with daily func-
tioning. This holds to a certain extent; patients who ex-
perience many problems with daily functioning might
not be able to do the monitoring anymore.
We investigated these hypotheses in a Dutch nation-




Data from 1294 participants of the National Panel of
people with Chronic illness or Disability (NPCD) were
used for this cross-sectional study [20]. This panel was
established by NIVEL (the Netherlands Institute for
Health Services Research) and is a nationwide prospect-
ive panel study in the Netherlands. Participants with a
chronic disease are recruited from random samples of
general practices in the Netherlands. The following cri-
teria were used for recruitment of the NPCD: being di-
agnosed with a somatic chronic disease (using the
International Classification of Primary Care (ICPC)) by a
certified medical doctor, being aged 15 or older, not be-
ing permanently institutionalized, being aware of the
diagnosis, not being terminally ill (a life expectancy of
more than six months according to their general practi-
tioner), being mentally capable of participating, and hav-
ing sufficient mastery of the Dutch language. Every year
500 new panel members are selected to replace panel
members who have withdrawn or who have participated
for the maximum term of four years. The NPCD can be
considered to be representative of the chronic disease
population in the Netherlands of aged 15 years and
older. The NPCD is registered with the Dutch Data Pro-
tection Authority. All data are collected and handled in
accordance with the privacy protection guidelines of the
Dutch authority.
Patients voluntarily participate in the NPCD. Participa-
tion has no influence on their care. Twice a year (spring
and autumn) the panel members voluntarily fill out a
questionnaire. The panel members could choose whether
they wanted to receive questionnaires by post, email or
phone. Some items used in this study were issued in the
spring questionnaire of 2014, others in the autumn
questionnaire of 2014. The questionnaire can be found in
Additional file 1.
In addition, to test our hypothesis regarding self-
monitoring of health data by people with different
chronic disease types an expert panel of 16 medical
doctors and physiotherapists was invited to participate
in a questionnaire study in February and March 2016.
Measurements
Participant characteristics
The background characteristics of the members of the
NPCD had already been gathered using a questionnaire
that was completed at inclusion in the panel. For this
study, the following characteristics were used: gender (1 =
male, 2 = female), age and level of education (1 = low
(primary school or preparatory vocational training), 2 =
middle (intermediate or advanced general education or
intermediate vocational training), 3 = high (high vocational
education or university)). In addition, information regard-
ing participants’ chronic disease(s) was provided at inclu-
sion by their general practitioner.
Self-monitoring of health data
The following question regarding self-monitoring of
health data was asked to participants in autumn 2014:
“Did you measure certain health data by yourself in the
past year, for example blood pressure, blood glucose
values or lung function?” Participants could answer: 1)
yes; 2), no, but I would like to do this (independently);
3), no, but I would like to do this together with a care
professional; or 4), no, and I do not want to do this.
Self-efficacy – patient specific
Patients’ perceived self-efficacy was collected using the
Dutch version of the general self-efficacy scale [21] in
spring 2014 (Cronbach’s alpha was 0.92). This question-
naire consists of ten questions with a four-point Likert
scale ranging from 1) completely wrong to 4) completely
right. For example: “When I am confronted with a prob-
lem, I can usually find several solutions” and “It is easy
for me to stick to my aims and accomplish my goals”.
Participants with four or more missing values were ex-
cluded. Mean values were used in further analyses, in
which a higher mean score indicates a higher level of
self-efficacy.
Problems in daily functioning – patient specific
The Dutch version of the Physical Health Composite
Score (PCS) of the SF-12 [22] was used to investigate
patients’ experienced problems in daily functioning in
autumn 2014 (Cronbach’s alpha was 0.88). The SF-12
has shown adequate validity and reliability in multiple
studies [23]. PCS scores were collected in spring 2014.
Mean scores were calculated using QualityMetric
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Health Outcomes™ Scoring Software 5.0 and could
range from 0 to 100, in which 100 indicates the highest
level of health.
Disease control – disease specific
To test the hypothesis, based on literature and experiences
regarding self-monitoring of health data by people with
different disease types (disease-specific hypothesis), nine
care professionals from the expert panel (six medical doc-
tors and three physiotherapists) out of sixteen experts
who were invited, answered the following question for 17
different chronic diseases: “To what extent can people
with a chronic disease, in general, independently keep
their disease under control (by means of nutrition, phys-
ical activity, medication etc.)?” Participants could respond
with: 1) not at all; 2) to some extent; or 3) to a large
extent. Mean scores per disease type were used in the
analyses.
Statistical analyses
Descriptive analyses were conducted to study participants’
characteristics per disease group. Participants were di-
vided into 17 different disease-type categories based on
the diagnosis of their first chronic disease (ischaemic heart
disease, hypertension, other cardiovascular disorders,
cancer, asthma, COPD, other respiratory diseases, dia-
betes, thyroid disorder, chronic back pain, rheumatism,
osteoarthritis, other musculoskeletal disorders, migraine,
other neurological disorders, digestive disorder and skin
disease). The most common diseases per disease category
can be found in Additional file 2.
Univariate logistic regression analyses were conducted
to test the relationship between patient- and disease-
specific characteristics, and patients’ willingness to self-
monitor health data (dependent variable: 1 = participants
who did measure certain health data by themselves +
participants who would like to do that (independently),
0 = participants who would like to do that together with
a care professional + participants who did not want to do
that at all). The univariate logistic regression analyses
were conducted with the following independent variables:
mean scores of the expert panel regarding disease control-
lability, mean score of the general self-efficacy scale, PCS
score of the SF-12 and age, gender (1 =male, 2 = female),
level of education (1 = low, 2 =middle, 3 = high) and mul-
timorbidity (0 = one disease, 1 = two or more diseases).
Assumptions for logistic regression were checked. We ad-
justed for clustering of data within chronic disease types
(patients within one disease group have the same disease
control score). Finally, multivariate logistic regression ana-
lyses were performed with all the above-mentioned con-
cepts (dependent variable: willingness to self-monitor).
Statistical analyses were performed using STATA 14.0.
Results
Participants
Figure 1 shows a flow chart of the process of the inclu-
sion of participants in this study. Out of 1294 partici-
pants of the NPCD, 979 responded to the questionnaire
that was issued in spring 2014. Of these 979 participants,
2 had no chronic disease or a disease that did not fit in
one of the 17 most prevalent chronic disease types (n =
67). Subsequently 101 participants were excluded because
of incomplete data regarding the self-monitoring question
(n = 44), PCS (n = 39) and level of education (n = 18). In
addition 160 participants were excluded because they did
not fill out the questionnaire at spring (n = 160) or be-
cause of incomplete data in the general self-efficacy scale
(n = 22). This resulted in a total sample of 627 partici-
pants. Non response analyses showed no differences in
Fig. 1 Flow chart of participants included in the study
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characteristics between the non-responders (including
people who responded but did not fill out the entire
questionnaire) and the final sample, except for age
(non-responders: M = 63.5, SE = 0.55; final sample: M =
65.1, SE = 0.46, t(1292) = −2.15, p = 0.03). So except for
a sampling bias of age the sample is representative of
the chronic disease population in the Netherlands.
Table 1 shows the characteristics of the study sample.
Diabetes (19.8%), other cardiovascular disorders (8.9%),
ischaemic heart disease/heart failure (8.6%) and asthma
(8.3%) were the most common chronic disease types
within the sample. Almost 4% of the participants were
diagnosed less than three years ago, 16.1% three to five
years ago, 31.9% six to ten years ago and almost half
(48.1%) longer than ten years ago. More than half (51.2%)
had been diagnosed with two or more chronic diseases.
All characteristics per disease group can be found in
Additional file 3.
Relationship of disease controllability with willingness to
self-monitor
Figure 2 represents the association between disease con-
trollability scores (assessed by the expert panel) and the
percentage of participants that is willing to self-monitor
health data per disease type. Patients’ willingness to self-
monitor differs greatly among disease types: patients
with diabetes (71.0%), asthma (59.6%) and hypertension
(59.1%) were most willing to self-monitor. In contrast,
patients with rheumatism (40.0%), migraine (41.2%) and
other neurological disorders (42.9%) were less willing to
self-monitor. In addition, the expert panel assessed dia-
betes (3.0), hypertension (2.7) and COPD and asthma
(2.6) as diseases that can be kept well under control by
the patient, and cancer (1.1), thyroid disorder (1.4), and
other neurological disorders and migraine (1.6) as the
diseases that are most difficult for the patient to keep
under control. The scores of the expert panel can be
found in Additional file 4.
A relationship is found between disease controllability
scores and patients’ willingness to self-monitor. The correl-
ation between disease controllability scores and the per-
centage of participants that is willing to self-monitor is
significant (r = 0.547, p < 0.05). In addition, looking at the
univariate and multivariate logistic association of disease
controllability with patients’ willingness to self-monitor
(first column Tables 2 and 3 respectively), a significant as-
sociation is found (univariate: OR = 1.589, 95% CI = 1.142–
2.210; multivariate: OR = 1.639, 95% CI = 1.129–2.380).
Diabetes group – disease controllability and willingness
to self-monitor
As can be seen in Fig. 2, all experts assessed diabetes as
a disease that can, to a large extent, be kept under con-
trol by the patient (the maximum mean score of 3.0). In
addition, the diabetes group scored remarkably high on
willingness to self-monitor (71.0%). Therefore, we decided
to look more deeply into the diabetes group only (n = 124).
Of the 124 people with diabetes, 9 participants have
type I diabetes and 103 type II (for 12 participants it is
unknown what type of diabetes they have). 41 participants
with diabetes use insulin (33.1%), 65 do not use insulin
(52.4%) and for 18 participants this is unknown (14.5%).
Of the 41 participants using insulin, 95.1% are willing to
self-monitor health data. In contrast, among patients who
are not using insulin 46.2% are willing to do so.
Table 1 Characteristics of the study sample
Characteristics Study sample (n = 627)
Mean (sd) or n (%)
Non response (n = 667)
Mean (sd) or n (%)
Age in years 65.1 (sd = 11.6) 63.5 (sd = 14.3)
Gender Male 313 (49.9%) 313 (46.9%)
Level of education Low 199 (31.7%) 220 (32.98%)
Medium 276 (44.0%) 276 (41.38%)
High 152 (24.2%) 122 (18.29%)
Missing = 49 (7.4%)
Chronic condition One 306 (48.8%) 321 (48.1%)
Two or more 321 (51.2%) 343 (51.4%)
Missing = 3 (0.5%)
Data collection By post 376 (60.9%)
Online 248 (39.6%)
By telephone 3 (0.5%)
General self-efficacy 3.12 (sd = 0.6)
Physical Health Composite Score 42.81 (sd = 11.4)
Willing to self-monitor 348 (55.5%)
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In Tables 2 and 3 (second column) it can be seen that
by excluding the entire diabetes group in the univariate
and multivariate logistic regression analyses to investigate
the relationship between disease controllability and pa-
tients’ willingness to self-monitor (n = 503), no signifi-
cant association is found (univariate: OR = 1.169, 95%
CI = 0.942–1.451; multivariate: OR = 1.164, 95% CI =
0.908–1.491).
Relationship of patient characteristics with willingness to
self-monitor
Patients’ perceived problems in daily functioning (PCS)
and self-efficacy have no significant association with their
willingness to self-monitor (see Tables 2 and 3). Age and
multimorbidity also have no relationship with willingness
to self-monitor. In contrast, males and more highly edu-
cated people are significantly more willing to self-monitor
their health data.
Looking at the diabetes sample only (Tables 2 and 3
third column), there was no significant association be-




This study provides the first evidence of an association
between disease controllability and patients’ willingness
to self-monitor health data. Against our expectations, no
Fig. 2 Mean disease controllability score (expert panel: 1 = not at all; 2 = to some extent; 3 = to a large extent) plotted against the percentage of
participants that is willing to monitor independently
Table 2 Univariate logistic regression analyses with the dependent variable: willingness to monitor health data
Entire sample (n = 627) Sample without diabetes (n = 503) Diabetes only (n = 124)
Independent variable OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age 0.994 (0.979–1.010) 0.453 0.994 (0.977–1.012) 0.519 0.973 (0.934-1.014) 0.193
Gender (ref = male) 0.728 (0.533–0.993) 0.045 0.669 (0.488–0.916) 0.012 1.800 (0.774–4.187) 0.172
Level of education (ref = low) – – – – – –
Intermediate 1.308 (0.863–1.983) 0.206 1.611 (1.158–2.240) 0.005 0.741 (0.308–1.784) 0.503
High 1.908 (1.300–2.801) 0.001 2.254 (1.603–3.170) <0.001 1.256 (0.435-3.627) 0.673
Multimorbidity (ref = one disease) 1.076 (0.816–1.420) 0.604 1.192 (0.902–1.577) 0.217 0.849 (0.390–1.850) 0.681
Disease control score (expert panel) 1.589 (1.142–2.210) 0.006 1.169 (0.942–1.451) 0.156 – –
Physical Health Composite Score (PCS) 1.005 (0.989–1.020) 0.567 1.002 (0.984–1.020) 0.823 1.003 (0.966–1.041) 0.874
Self-efficacy patient 0.994 (0.747–1.322) 0.968 1.062 (0.760–1.483) 0.724 0.747 (0.374–1.492) 0.408
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evidence is found for a relationship between self-efficacy
and the severity of problems that patients experience
with daily functioning, and patients’ willingness to self-
monitor. In addition, it is found that males and more
highly educated people are more willing to self-monitor
their health data.
The scores of the diabetes group regarding disease
controllability and patients’ willingness to self-monitor
were remarkably high. Patients with diabetes using insu-
lin were particularly willing to self-monitor (95.1%). The
difference between diabetes and other chronic disease
types regarding self-monitoring could be explained by
the fact that for diabetes patients self-monitoring is rec-
ommended as an integral component of their treatment
(particularly for patients using insulin) [24, 25]. So for
many persons with diabetes, their “willingness” to self-
monitor is beyond question, because they have to monitor
their blood glucose level for their (optimal) treatment.
Hence, as we found in this study, this is also independent
of the patient characteristics they have. For other chronic
disease types self-monitoring is often not yet integrated
into the standard treatment. For these chronic disease
types males and more highly educated people were more
willing to self-monitor, which is in line with some, but not
all, self-management research [26–28]. Interestingly, we
did not find a relationship between multimorbidity
(having two or more chronic conditions) and willingness
to self-monitor. Although many research found that
performing optimal self-management behaviour may be
more challenging for people with multiple chronic dis-
eases [29, 30], this study suggest that this does not in-
fluence willingness to self-monitor.
Contrary to our expectations no effect of self-efficacy
on patients’ willingness to self-monitor was found in this
study. However, in other studies that did find an associ-
ation between self-efficacy and self-monitoring, question-
naires were used to investigate self-efficacy regarding
patients’ chronic disease, such as how participants assessed
their capability to monitor, plan and carry out activities for
their disease (for example nutrition, physical exercises and
medication) [16, 17]. In the current study the general
self-efficacy scale [21] was used, which consists of gen-
eric questions such as “When I am confronted with a
problem, I can usually find several solutions” and “It is
easy for me to stick to my aims and accomplish my
goals”. It appears that patients’ general self-efficacy is
not related to their willingness to self-monitor. In future
research it might be interesting to investigate if a chronic
disease self-efficacy scale, e.g., the Chronic Diseases Self-
Efficacy Scale of Lorig and colleagues [31] is related to
willingness to self-monitor.
No relationship was found between patients’ perceived
problems in daily functioning and self-monitoring, which
is not in line with our hypothesis. Again, participants were
asked to assess all their general health problems in daily
functioning, and not only the physical problems related to
their specific chronic disease. Although we found some
support for this possible relationship in our recently per-
formed focus group study [13], other research regarding
eHealth did not find a relationship between health needs
and patients’ acceptance and interests of eHealth as well
[32, 33]. It seems that patients’ willingness to self-monitor
health data is not directly related to their perceived health
problems. In future research it might be interesting to in-
vestigate if a disease specific health scale (such as Quality
of life Disease Impact Scale [34]) has an influence on pa-
tients’ willingness to self-monitor. In addition, although
we did not ask participants to indicate their expected or
perceived benefits of self-monitoring health data, it might
be expected that willingness to self-monitor is more re-
lated to the overall concepts of “perceived benefits” and
“perceived usefulness”, which are well-studied concepts in
care technology acceptance research [8, 19, 35–37]. It
might be that patients are more willing to self-monitor
when they believe that self-monitoring can convey (health)
benefits.
This study provides the first evidence that patients’
willingness to self-monitor might be associated with
Table 3 Multivariate logistic regression analyses with the dependent variable: willingness to monitor health data
Entire sample (n = 627) Sample without diabetes (n = 503) Diabetes only (n = 124)
Independent variable OR (95% CI) p OR (95% CI) p OR (95% CI) p
Age 0.992 (0.976–1.008) 0.312 0.993 (0.974–1.012) 0.468 0.972 (0.929–1.018) 0.229
Gender (ref = male) 0.792 (0.522–1.203) 0.274 0.655 (0.468–0.916) 0.013 1.934 (0.783–4.776) 0.153
Level of education (ref = low) – – – – – –
Intermediate 1.491 (0.973–2.284) 0.067 1.804 (1.256–2.590) 0.001 0.652 (0.250–1.701) 0.382
High 2.042 (1.415–2.950) <0.001 2.344 (1.645–3.341) <0.001 1.217 (0.398–3.724) 0.730
Multimorbidity (ref = one disease) 1.170 (0.868–1.576) 0.303 1.278 (0.903–1.809) 0.167 0.876 (0.386–1.988) 0.751
Disease control score (expert panel) 1.639 (1.129–2.380) 0.009 1.164 (0.908–1.491) 0.230 – –
Physical Health Composite Score (PCS) 1.001 (0.984–1.019) 0.916 0.999 (0.979–1.020) 0.934 1.008 (0.962–1.057) 0.726
Self-efficacy patient 0.862 (0.655–1.134) 0.288 0.881 (0.636–1.221) 0.448 0.757 (0.346–1.656) 0.486
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disease controllability. Further research should investigate
this association more deeply and should focus on how dis-
ease controllability influences willingness to self-monitor.
In the current study disease controllability is investigated
using one general question in an expert panel (“To what
extent can people with a chronic disease, in general, inde-
pendently keep their disease under control (by means of
nutrition, physical activity, medication etc.) for the follow-
ing chronic diseases?”). It is recommended to first define
the concept of disease controllability and to investigate
what factors and mechanisms play a role in this. Secondly,
it should be investigated how disease controllability influ-
ences patients’ willingness to self-monitor, for example by
using qualitative methodology focusing on behavioural
and motivational aspects of patients. Thirdly, it should be
investigated how self-monitoring applications for different
disease types can be adapted to improve this. In addition,
it should be investigated what other disease- and patient
specific factors play a role in patients’ willingness to
self-monitor, such as disease effects, patients’ perceived
controllability of symptoms and patients’ coping and at-
titudes toward their disease. This study shows that the
percentage of participants that is willing to self-monitor
health data differed greatly between disease types. Hence,
while developing and offering self-monitoring applications
it should be kept in mind that not all patient groups are
willing to self-monitor their health data.
Strengths and limitations
The strength of this study is its general focus on patients’
willingness to self-monitor health data in a broad sample
(n = 627) of people with the most common chronic som-
atic disease types (17 chronic disease types). The panel
used for this study was representative of the Dutch
chronic disease population (except for age). The overall
response of this panel is high and participants were not re-
cruited for the specific topic of this study which minimizes
selection bias; items used for this study were a part of a
panel questionnaire. In addition, this study is conducted
to test our hypotheses, which were based on the results of
a recently performed focus group study [13]. Moreover, to
the best of our knowledge, this is the first study to in-
vestigate the relationship between the controllability of
certain chronic disease types and patients’ willingness
to self-monitor.
As mentioned before, one limitation of this study is
that data from general questionnaires have been used to
investigate patients’ self-efficacy and physical problems
that were not specifically related to patients’ chronic
disease. In addition, the dependent variable ‘patients’
willingness to self-monitor’ was based on one non-validated
question. Furthermore, patients’ willingness to self-monitor
and their Physical health Composite Scores (PCS) were col-
lected in autumn 2014, in contrast to general self-efficacy
scores, which were investigated in spring 2014. However, it
is expected that these scores did not significantly change
within six months. In addition, the number of people within
a disease type highly differed from n = 6 (chronic back pain)
to n = 124 (diabetes). Five chronic disease types had only 20
or less participants. In addition, in the analyses with the
diabetes group only, no relationships were found be-
tween gender and education level, and patients’ willing-
ness to self-monitor. This might be explained by the
lower number of participants compared with the entire
sample (n = 124 vs n = 627). Moreover, no relationship
between multimorbidity and patients’ willingness to
self-monitor was found in this study. We defined multi-
morbidity as having two or more chronic conditions. It
might be that this does not reflect the complexity of
this problem, in particular not for people with a high
number of conditions.
Another limitation is that people that had done self-
monitoring in the previous year and those that wanted
to do so independently were recoded as being willing to
self-monitor. Additional separate analyses were performed
to investigate differences between the association of the
actual self-monitoring group or the willing to self-monitor
group on the one hand, and disease controllability on the
other. Although similar positive associations between the
actual and willing to self-monitor group, and disease con-
trollability were found, no valid statements could be made
due to the small number of people in each (disease) group.
In addition, it is assumed that the actual self-monitoring
group were also willing to self-monitor in the first place.
Moreover, participants that wanted to do self-monitoring
with the help of a care professional and participants that
did not want to do self-monitoring at all were recoded as
being not willing to self-monitor, because we were particu-
larly interested in people that were willing to self-monitor
independently. This because we consider self-monitoring
as a core element of self-management and by monitoring
independently the required effects of self-monitoring
(improving symptom management, disease regulation,
patients’ coping and attitudes toward their disease, real-
istic goal setting and an enhanced quality of life [6])
will be most effective.
Conclusion
This study provides the first evidence that patients’ will-
ingness to self-monitor might be associated with disease
controllability. Further research should investigate this
association more deeply and should focus on how disease
controllability influences willingness to self-monitor. In
addition, it should be investigated what other disease- and
patient specific factors play a role in patients’ willingness
to self-monitor. No evidence is found of a relationship be-
tween self-efficacy and the severity of problems that pa-
tients experience with daily functioning, and patients’
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willingness to self-monitor. Since the percentage of par-
ticipants that is willing to self-monitor health data dif-
fered greatly between disease types, it should be taken
into account that not all patient groups are willing to
self-monitor their health data.
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